Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co (HTSUF)
:HTSUF
HTSUF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.04 - $32.30
Previous CloseN/A
Volume30.00
Average Volume (3M)0.00
Market Cap
$2.24B
Enterprise Value$198.51B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)20.4
Beta0.19
Next Earnings
Apr 10, 2025EPS EstimateN/A
Next Dividend Ex-Date
Feb 27, 2025Dividend Yield2.05%
Share Statistics
EPS (TTM)1.39
Shares Outstanding85,164,894
10 Day Avg. Volume0
30 Day Avg. Volume0
Standard Deviation0.12
R-Squared0.00857
Alpha-0.00380
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Hisamitsu Pharmaceutical Co News
PremiumCompany Announcements
Hisamitsu Pharmaceutical Co. Reports Q2 GrowthPremiumPre-Earnings
Is HTSUF a Buy, Before Earnings?
PremiumCompany Announcements
Hisamitsu Pharma Reports Strong Q1 Results---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.39% Mutual Funds
― Other Institutional Investors
93.85% Public Companies and
Individual Investors
HTSUF FAQ
What was Hisamitsu Pharmaceutical Co ’s price range in the past 12 months?
Hisamitsu Pharmaceutical Co lowest stock price was $21.04 and its highest was $32.30 in the past 12 months.
What is Hisamitsu Pharmaceutical Co ’s market cap?
Hisamitsu Pharmaceutical Co ’s market cap is $2.24B.
When is Hisamitsu Pharmaceutical Co ’s upcoming earnings report date?
Hisamitsu Pharmaceutical Co ’s upcoming earnings report date is Apr 10, 2025 which is in 47 days.
How were Hisamitsu Pharmaceutical Co ’s earnings last quarter?
Hisamitsu Pharmaceutical Co released its earnings results on Jan 09, 2025. The company reported $0.415 earnings per share for the quarter, beating the consensus estimate of N/A by $0.415.
Is Hisamitsu Pharmaceutical Co overvalued?
According to Wall Street analysts Hisamitsu Pharmaceutical Co ’s price is currently Overvalued.
Does Hisamitsu Pharmaceutical Co pay dividends?
Hisamitsu Pharmaceutical Co pays a Semiannually dividend of $0.282 which represents an annual dividend yield of 2.05%. See more information on Hisamitsu Pharmaceutical Co dividends here
What is Hisamitsu Pharmaceutical Co ’s EPS estimate?
Hisamitsu Pharmaceutical Co ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hisamitsu Pharmaceutical Co have?
Hisamitsu Pharmaceutical Co has 85,164,894 shares outstanding.
What happened to Hisamitsu Pharmaceutical Co ’s price movement after its last earnings report?
Hisamitsu Pharmaceutical Co reported an EPS of $0.415 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.555%.
Which hedge fund is a major shareholder of Hisamitsu Pharmaceutical Co ?
Currently, no hedge funds are holding shares in HTSUF
---
Company Description
Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
---
Technical Analysis
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Sumitomo Dainippon Pharma Co
―
Eisai Co
―
Shionogi & Co
―
---